Air Power has sold a majority stake to Entangled Capital
The shareholders or Air Power have sold a majority stake in the company to Entangled Capital SGR S.p.A.
Air Power is a family-owned company and is one of the leading Italian manufacturers of machines for the ceramic sector. The company designs and manufactures machinery for the industrial processing of ceramics: conveyor lines for tiles, machinery for moving tiles and application machinery for wet and dry glazing. In 2021, the company recorded revenues of US$26 million (of which 40% in Asia, 30% in Italy, 18% in Europe and 10% in America) and US$5 million EBITDA.
Entangled Capital SGR is an independent Italian asset management firm that promotes and manages a private equity direct fund in small mid-cap companies, with an operative approach combining the track record of the investment team with the industrial experience of the operating partners.
Oaklins’ team in Italy acted as the exclusive financial advisor to Air Power in this transaction.
Talk to the deal team
Related deals
Sunlight Group has acquired a 51% stake in Lehmann Marine GmbH
Through its acquisition of a 51% stake in Lehmann Marine GmbH, Sunlight Group continues to strengthen its position in the growing energy solutions market, while expanding its portfolio of innovative technologies. With over 30 years of expertise in producing lead-acid and lithium-ion batteries, Sunlight Group has established itself as a leader in advanced battery technology.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more